Reaction
Faecal Volume Increased reporting signals
As of the last recalculation, Faecal Volume Increased appears in 518 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 157.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Teduglutide | 48 | 157.7 | 158.2 |
| Orlistat | 10 | 15.8 | 15.8 |
| Linaclotide | 10 | 15.3 | 15.3 |
| Patiromer | 4 | 11.7 | 11.7 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 3 | 9.7 | 9.7 |
| Palivizumab | 3 | 7.9 | 7.9 |